Thromboxane A2
WikiDoc Resources for Thromboxane A2 |
Articles |
---|
Most recent articles on Thromboxane A2 Most cited articles on Thromboxane A2 |
Media |
Powerpoint slides on Thromboxane A2 |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thromboxane A2 at Clinical Trials.gov Trial results on Thromboxane A2 Clinical Trials on Thromboxane A2 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thromboxane A2 NICE Guidance on Thromboxane A2
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thromboxane A2 Discussion groups on Thromboxane A2 Patient Handouts on Thromboxane A2 Directions to Hospitals Treating Thromboxane A2 Risk calculators and risk factors for Thromboxane A2
|
Healthcare Provider Resources |
Causes & Risk Factors for Thromboxane A2 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Thromboxane A2 is a thromboxane. It is generated from prostaglandin H2 by thromboxane-A synthase. It is also a major component of blood clots. Aspirin irriversibly inhibits platelet cyclooxygenase preventing the formation of prostaglandin H2, and therefore Thromboxane A2.